T he ATP-sensitive potassium (K ATP ) channels respond to transmitters and changes in the internal metabolic state, thereby controlling insulin release and vascular tone and protecting neurons and muscles against hypoxic, hypoglycemic, or ischemic stress (1). Indeed, the role of K ATP channels as critical sensors in protection against acute metabolic stress has been further supported by recent gene targeting studies (2).
T
he ATP-sensitive potassium (K ATP ) channels respond to transmitters and changes in the internal metabolic state, thereby controlling insulin release and vascular tone and protecting neurons and muscles against hypoxic, hypoglycemic, or ischemic stress (1) . Indeed, the role of K ATP channels as critical sensors in protection against acute metabolic stress has been further supported by recent gene targeting studies (2) .
Free radical NO is a biologically active messenger (3, 4) . Physiological functions of NO include regulation of blood flow (5), cell-mediated immune response, neuronal signaling, synaptic plasticity (6, 7) , and heart structure and function (8) . Targets for NO include ion channels, soluble guanylyl cyclase (GC) (9) , and Ras, a family of small monomeric GTPases (10), among others. Ras functions as molecular switches in the transduction of extracellular signals to the cytoplasm and nucleus (11, 12) . Active Ras binds to and activates effector proteins, including members of the Raf family, phosphatidylinositol 3-kinase (PI3-kinase), and members of the Ral-specific guanine nucleotide exchange factor family (12, 13) . Activation of Raf leads to activation of mitogen-activated protein kinase (MAPK) kinase (MEK) and extracellular signal-regulated kinase (ERK) (14) . Neuronal ischemic preconditioning (IPC), modeled in vitro by oxygen-glucose deprivation (OGD) of cultured cortical neurons, requires the Ras͞ERK cascade activated by NO (15) . ERK is also activated in hippocampus after sublethal ischemia (16) and in myocardium after ischemia-reperfusion (17) .
NO, Ras, and K ATP channels appear to serve some common physiological functions, such as vasodilation and neuroprotection under ischemia. Whether K ATP is a downstream effector of NO is not known. In this study, we first demonstrate that NO modulates Kir6.2͞sulfonylurea receptor (SUR) 2B channels expressed in transfected human embryonic kidney (HEK) 293 cells. We then show that NO stimulates K ATP channels via the Ras͞MAPK pathway but not the PI3-kinase pathway; the activation of the GC pathway is not required. Finally, after investigating the role of K ATP channels in OGD preconditioning of cultured rat hippocampal neurons, we report that the neuroprotection effect of late IPC in primary hippocampal cells requires the activities of NO synthase (NOS) and the K ATP channel, which suggests a physiological role of the NO-K ATP pathway in neuroprotection afforded by IPC.
Materials and Methods
Construction of cDNAs and Transient Transfection. Mutation of C118 on Ras to a serine residue was made by site-directed mutagenesis. cDNAs encoding SUR2B (rat) and Kir6.2 (mouse) in pcDNA3 (Invitrogen), as well as pCMV-Ras, pCMV-RasV12, pCMV-RasN17 (Clontech), and pCMV-RasC118S were prepared by using Qiagen (Valencia, CA) maxipreps. HEK293 cells were maintained and transiently transfected as described (18) .
Preparations of Drugs. Noc-18, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (P TIO), 1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one (ODQ), 8-Br-cGMP, farnesyltransferase (FPT) inhibitor III, PD98059, LY294002, L-Arg, and N G -monomethyl-L-arginine, monoacetate salt (L-NMMA) were obtained from Calbiochem, glibenclamide was obtained from Sigma, and the aliquots from frozen stocks prepared in appropriate solvents were diluted with bath recording solution to desired concentrations before use. Drugs were either applied through a gravity-driven bath-perfusion system while channel activities were monitored or added into the culture dish for preincubation.
KOH, 10 mM EGTA, and 10 mM Hepes, pH 7.2. The extracellular (intrapipette) solution consisted of 140 mM KCl, 1.2 mM MgCl 2 , 2.6 mM CaCl 2 , and 10 mM Hepes, pH 7.4. All salts were obtained from Sigma. Cell-attached single-channel recordings (19) were performed at room temperature 48-72 h after transfection. All patches were voltage-clamped at Ϫ60 mV intracellularly. Currents were recorded with Axopatch 200A amplifier (Axon Instruments, Foster City, CA) and were low-pass filtered (1 kHz) and digitized at 20 kHz. Single-channel events were detected by using FETCHAN 6 .05 (pCLAMP; Axon Instruments) and analyzed with INTRV5 (a gift from Barry S. Pallotta, University of North Carolina, Chapel Hill) as described (18) .
OGD and Cell Viability Assays of Neurons. Primarily cultured hippocampal neurons were prepared from embryonic day 19 rat (20) , and OGD experiments were performed at days 13-21 in vitro. Combined OGD was performed by changing media with deoxygenated glucose-free Earle's balanced salt solution, and cultures were kept in an anaerobic system during 10 (first OGD) and 90 (second OGD) min at 37°C with a 24-h interval. Cell viability assay was performed 24 h after the 90-min OGD. See Supporting Materials and Methods, which is published as supporting information on the PNAS web site, for details.
Statistics. Data were averaged and presented as mean Ϯ SEM. Statistical comparisons were made by using Student's one-tailed, unpaired t tests (for absolute data) or one-sample t test (for paired normalized data). Significance was assumed when P Ͻ 0.05. Single-channel activities were monitored continuously in cellattached patches. Single-channel openings, most frequently at a conductance level around 63 pS (between Ϫ30 and Ϫ100 mV), appear as upward deflections (Fig. 1) . Bath perfusion of the NO donor Noc-18 caused Kir6.2͞SUR2B channel activities to increase over the course of several minutes. Because this stimulation could not be fully reversed by washout, we compared channel activities at the plateau of Noc-18 effect with controls obtained right before application of Noc-18. In contrast to the infrequent and brief channel openings in the control, the singlechannel currents increased after Noc-18 treatment, resulting in simultaneous openings of three channels in this patch (Fig. 1 A1) . Whereas the single-channel conductance level remained unaltered, Noc-18 treatment produced statistically significant changes in the single-channel properties: the open probability (NPo), opening frequency, and the mean open time increased whereas mean closed time decreased (five patches; Fig. 1 A2) . The normalized fold changes (control as 1) are 9.11 Ϯ 2.90 (P Ͻ 0.05), 8.26 Ϯ 2.36 (P Ͻ 0.05), 1.14 Ϯ 0.05 (P Ͻ 0.05), and 0.22 Ϯ 0.11 (P Ͻ 0.001) for NPo, opening frequency, mean open time, and mean closed time, respectively (Fig. 1 A2) . To determine whether the effect of Noc-18 was due to release of NO, we applied PTIO, a NO scavenger, together with Noc-18. Not only did coapplication of PTIO abolish the Kir6.2͞SUR2B channel stimulation by Noc-18 ( Fig. 1B1 ), but it also reduced NPo and opening frequency compared with controls obtained before the drug treatment (Fig. 1B2 , four to six patches), probably because of the removal of endogenous NO by PTIO. These data indicate that NO released from NO donor Noc-18 significantly increases the single-channel activity of recombinant Kir6.2͞SUR2B channels. In contrast, the NO effects on Kir6.2⌬C36 expressed in the absence of SUR (21) were much more variable, and only the opening frequency was significantly increased (4.89 Ϯ 2.00, P Ͻ 0.05; nine patches; data not shown) by Noc-18, which implies a weaker effect of NO on the Kir6.2 subunit compared with Kir6.2͞SUR2B. In addition, when Noc-18 was applied to the excised, inside-out membrane patches expressing Kir6.2͞ SUR2B channels, Noc-18 failed to stimulate channel activities (data not shown), indicating that the NO effects on Kir6.2͞ SUR2B channels are unlikely to result from direct channel modification.
Results

Stimulation of
KATP Channel Stimulation by Noc-18 Is Not Blocked by the GC Inhibitor.
Some of the physiological actions of NO are thought to be mediated by cGMP because of the activation of GC (22, 23) . Several studies have shown that K ATP channel activity is either decreased (24) or increased (25) by the cGMP-dependent phosphorylation process. To test whether NO modulates Kir6.2͞ SUR2B channels via a cGMP-dependent pathway, we first applied 8-Br-cGMP, a membrane-permeable cGMP analog, and found that the single-channel activities of Kir6.2͞SUR2B channels in cell-attached patches were stimulated (Figs. 1C1; seven patches in Fig. 1C2 ). We then examined whether K ATP stimulation by Noc-18 was blocked by ODQ, a potent and selective inhibitor of GC. This GC inhibitor did not abolish NO stimulation (Fig. 1D1) ; NPo, opening frequency, and open time were all significantly increased (P Ͻ 0.05), whereas the mean closed time was decreased (P Ͻ 0.0001) ( Fig. 1D2; eight patches) . Thus, NO stimulation of Kir6.2͞SUR2B channel activities appears to be mediated primarily via a pathway independent of GC activity; the GC pathway is not required.
KATP Channel Stimulation by NO Is Diminished by Inhibition of Ras or
MEK. To test whether NO stimulation of K ATP channels was mediated by means of Ras, we examined the effects of FPT inhibitor III (FPT Inh III), a cell-permeable inhibitor of farnesyltransferase that is required for Ras processing (farnesylation) and plasma membrane association. Coapplication of Noc-18 and FPT Inh III after FPT Inh III pretreatment caused channel inhibition rather than stimulation ( Fig. 2A1 ; five to seven patches in Fig. 2 A2) . Another way to disrupt Ras function is to express RasN17, a dominant-negative form of Ras (26) . Indeed, the Kir6.2͞SUR2B single-channel activities in cells coexpressing RasN17 were not increased by Noc-18 ( Fig. 3C1 ; four patches in Fig. 3C2 ). These data indicate that Ras activity is required for NO-mediated stimulation of Kir6.2͞SUR2B channels.
How might NO activate Ras to stimulate K ATP ? Ras can be modified directly by NO through S-nitrosylation at Cys-118 of Ras (27) by promoting the guanine nucleotide exchange of Ras (28) . Coexpression of RasC118S with the channel prevented K ATP channel stimulation by Noc-18 ( Fig. 3D1 ; four patches in Fig. 3D2 ). How might Ras stimulate K ATP ? One of the signaling cascades downstream of Ras is the MAPK pathway (29) . We tested the involvement of MAPK cascade by treating cells with PD98059, a selective and cell-permeable inhibitor of MEK. The kinase inhibitor caused K ATP channels to be inhibited rather than stimulated by Noc-18 ( Fig. 2B1 ; four patches in Fig. 2B2 ). Thus, like inhibition of Ras by FPT inhibitor III (Fig. 2 A2) , inhibition of MEK by PD98059 unmasked an inhibitory effect of NO. Multiple MEK͞MAPK pathways may exist in these cells; whereas NO stimulates the MEK͞MAPK pathway that activates Kir6.2͞SUR2B channels, other MEK͞MAPK pathway(s) may mediate channel inhibition. Precedence for multiple MAPK pathways with shared and specific kinase components has been established in yeast (30) . Data were normalized and compared as described for Fig. 1 . * , P Ͻ 0.05.
NO Stimulation of SUR2B͞Kir6.2 Channels Is Not Abolished by Block-
ade of PI3-Kinase Activity. Besides the MEK pathway, Ras activates PI3-kinase in antiapoptotic signaling (31) . Treatment with LY294002, a specific PI3-kinase inhibitor, at room temperature for at least 15 min did not prevent channel stimulation by subsequent coapplication of Noc-18 and LY294002 (Fig. 2C1) Coexpression of RasV12, an activated form of Ras (32), with Kir6.2͞SUR2B channels significantly raised the basal channel activity compared with cells expressing only the channels (Table  1 , which is published as supporting information on the PNAS web site). Moreover, RasV12 coexpression prevented further stimulation of channel activities by NO donor (Fig. 3 B1 and B2 ; five patches). These findings reinforce the notion that NO stimulation of K ATP is mediated by Ras. See Supporting Results, which is published as supporting information on the PNAS web site, for details.
KATP Stimulation by L-Arg, Precursor of Endogenously Produced NO, Is
Blocked by the NOS Inhibitor L-NMMA. NOS catalyzes the oxidation of L-arginine (L-Arg) to L-citrulline, leading to the generation of NO. Bath perfusion of L-Arg increased Kir6.2͞SUR2B singlechannel activity (Fig. 4A1) . The opening frequency was significantly increased, whereas the mean closed time was reduced (Fig. 4A2 ) (P Ͻ 0.05 for both; two to five patches). To determine the specificity of such effects, we applied a competitive NOS inhibitor, L-NMMA, together with L-Arg. L-NMMA blocked the stimulatory effect of L-Arg on Kir6.2͞SUR2B (Figs. 4B1; four patches in Fig. 4B2 ). Similar stimulatory effects of L-Arg were evident if the cells were transfected with cDNAs encoding Kir6.2, SUR2B, and wild-type Ras, although only the change of mean closed time reached statistical significance ( Fig. 4C1 ; five to six patches in Fig. 4C2 ). No such trend of current increase was found when L-Arg was coapplied with L-NMMA to patches coexpressing Kir6.2, SUR2B, and Ras (Fig. 4D1) . Instead, the NOS inhibitor reduced channel activity by decreasing NPo and lengthening the mean closed time (P Ͻ 0.05; three patches; Fig.  4D2 ). Consistent with our experiments with the NO scavenger PTIO (Fig. 1B) , these data provide further evidence that NO generated by endogenous NOS stimulates K ATP channels. Although HEK293 cells may not express a high amount of endogenous NOS, apparently it was sufficient for L-Arg to induce NO production and stimulate K ATP in our experiments.
L-Arg, When Applied to Cells Coexpressing RasN17 and KATP Channels,
Fails to Increase the Channel Activities. To test whether Ras mediates channel stimulation by NO produced by endogenous NOS, we examined the effect of dominant-negative Ras. When L-Arg was applied to the cells expressing not only Kir6.2 and SUR2B subunits but also RasN17, there was no increase of the channel function by L-Arg ( Fig. 4E1 ; two to five patches in Fig. 4E2 ), indicating that K ATP stimulation by endogenous NO relies on the Ras signaling pathway. Moreover, blockade of Ras activation by RasN17 revealed an inhibitory effect of NO, decreasing NPo and prolonging the mean closed time (P Ͻ 0.05), similar to the Noc-18-induced channel inhibition that was unmasked by inhibitor of Ras farnesylation (FPT inhibitor III) or by MEK inhibitor (PD98059) (Fig. 2 A and B) . These findings indicate that Ras͞MEK activation by NO overrides or overshadows a Rasindependent pathway for channel inhibition by NO and causes NO to increase channel openings severalfold.
Blockade of KATP Activity Reduces Cell Viability in Late Neuronal IPC.
Neurons may be protected from the lethal effects of prolonged ischemia by preceding brief periods of ischemia. The protective effects have been observed both early, within a few hours of IPC (early IPC), and late, days after IPC (late IPC) (33) . This neuronal IPC can be modeled in vitro by OGD. In cortical neurons, OGD preconditioning induces Ras activation in an N-methyl-D-aspartate-and NO-dependent manner; moreover, ERK cascade downstream of Ras is required for late IPC (15). Given that many components of the signaling pathway for neuronal late IPC are also used during NO stimulation of K ATP , we wondered whether the K ATP channel plays a role in neuronal IPC. To test this, we treated primarily cultured hippocampal neurons from rats with glibenclamide (5 M), a K ATP channel inhibitor, during the short period of OGD and assayed the cell viability after a prolonged ischemia (see Materials and Methods). Exposure to a 10-min OGD given 24 h earlier (first OGD) greatly enhanced survival of hippocampal neurons after a 90-min OGD assault (second OGD) (normalized cell viability rate 71.80 Ϯ 3.13%, n ϭ 8; Fig. 5 A and E) compared with control without prior brief exposure to OGD (23.45 Ϯ 3.84%, n ϭ 8; Fig. 5 B and E) (P Ͻ 0.001). This protection requires K ATP as well as NOS activity: the cell viability was significantly reduced by glibenclamide (26.33 Ϯ 5.68%, n ϭ 8; Fig. 5 C and E) (P Ͻ 0.001) or L-NMMA (23.75 Ϯ 3.49%, n ϭ 6; Fig. 5 D and E) (P Ͻ 0.001) applied during first OGD. Thus, NO stimulation of K ATP in hippocampal neurons may promote neuronal survival in OGD preconditioning.
Discussion
Both NO and K ATP have been implicated in neuroprotection and blood flow regulation, raising the intriguing question of whether NO exerts its protective functions partly by modulating K ATP channels. Our observations reveal that K ATP is stimulated via the Ras signaling pathway in response to NO derived from either chemical NO donors or the natural NOS substrate L-Arg. Like Ras, the MEK in the Ras pathway is necessary for K ATP channel activation by NO, but not PI3-kinase or GC. Hypoxia or ischemia may induce the production of NO. Our findings that the protective effect of IPC in hippocampal neurons was abolished by inhibition of K ATP or NOS raise the possibility that NO stimulation of K ATP channels via Ras͞MAPK cascade could cause hyperpolarization, thereby increasing blood flow, reducing neuronal excitability, and protecting neurons against excitotoxicity, and implicate NO modulation of K ATP in the neuroprotection afforded by late ischemic preconditioning. The mechanistic link between MAPK activation and K ATP stimulation remains to be determined. -activated potassium (BK Ca ) channels (35) . NO may activate the BK Ca channel either directly (36, 37) or indirectly by means of cGMP-dependent protein kinase (38) . We have found no evidence for direct activation of K ATP channels by NO; NO application to excised patches had no stimulatory effects on Kir6.2͞SUR2B channels (data not shown). The slow time course of K ATP channel stimulation would be consistent with the involvement of a multistep pathway downstream of NO.
NO
Stimulation of KATP Channels Requires Ras and MEK͞MAPK but Not
PI3-Kinase or GC. Previously it had been shown that the K ATP channel is regulated by a cGMP-dependent protein kinasesignaling pathway (24, 25, 39) . In this study, although the Kir6.2͞SUR2B channel is stimulated by a cGMP-dependent process, the action of NO to stimulate the channel does not require it. In line with this, Shinbo and Iijima (40) have suggested that NO-mediated potentiation of K ATP activated by K ϩ channel openers is independent of the cGMP͞cGMP-dependent protein kinase-signaling pathway in the heart. NO can modify proteins involved in the signaling mechanism by chemical reaction such as S-nitrosylation other than by means of activation of GC (41) . Indeed, our data on RasC118S (Fig. 3D) suggest that the NO effects on the K ATP channel require activation of Ras by means of S-nitrosylation. Downstream of Ras, the MAPK pathway rather than the PI3-kinase pathway is responsible for mediating NO modulation of K ATP channels (Fig. 2 B and C) . We also found that NO stimulation of K ATP channel activity may require new protein synthesis (data not shown). Given the many evolutionarily conserved functions of MAPK, including the phosphorylation of transcription factors (42, 43) , NO stimulation of K ATP could conceivably result from altered transcription and translation or phosphorylation of either the channel proteins or other regulatory proteins, which remains to be determined. It is also worth noting that inhibition of the Ras͞MEK signaling pathway unmasked an inhibitory effect of NO. This channel inhibition is not likely to be mediated by cGMP, because 8-Br-cGMP has a stimulatory effect on these channels. It is possible that NO activates K ATP via the Ras pathway but inhibits K ATP channels via a Ras-independent pathway, resulting in a net stimulation. Alternatively, Ras͞MEK activation by NO may not only activate K ATP but also suppress the ability of NO to inhibit K ATP via an as yet unknown pathway. It would be of interest to explore conditions that differentially modulate the different NO effects on K ATP channels. NO and KATP Channels in the Brain: Role of KATP in Neuronal IPC. K ATP channel activation may contribute to changes in neuronal excitability and protection of neurons from cell death caused by ischemia, hypoxia, or metabolic stress, by inducing membrane hyperpolarization (44) . Indeed, pretreatment of rat neocortical brain slices with K ATP openers is neuroprotective, counteracting hypoxia-induced cell injury (45) . Studies of K ATP channels in midbrain dopaminergic neurons in weaver mice further indicate that these channels may be protective against neurodegeneration (46) .
The late preconditioning in the heart is mediated by increased synthesis of NO by inducible NOS (47) . The mechanism whereby NO protects during late preconditioning remains speculative. In the brain, IPC protection against lethal ischemia is mediated largely by the activation of N-methyl-D-aspartate receptors through increases in intracellular Ca 2ϩ (48) . The activation of adenosine A1 receptors, PKC, or K ATP channels may also be involved (49, 50) . K ATP channels may be involved in neuroprotection afforded by anoxic preconditioning in hippocampal slices (50) . OGD preconditioning of cultured cortical neurons requires Ras and MAPK͞ERK activation, which is induced in an Nmethyl-D-aspartate receptor-and NO-dependent, but cGMPindependent, manner (15) . In this study, we demonstrate that both K ATP channel activation and NO generation are required for OGD preconditioning of rat hippocampal neurons (Fig. 5) , implicating NO and K ATP in ischemic preconditioning in vivo. One potential pathway of neuronal IPC may involve NO activation of K ATP via the Ras͞MAPK signaling cascade; follow-up studies are required to elucidate the detailed mechanism in neurons.
NO has been implicated in neuronal signaling and synaptic plasticity (6, 7) . The Ras͞MAPK pathway underlying NOmediated enhancement of K ATP channel function may play important roles in mediating or modulating activity-induced changes such as neuronal differentiation, synaptic strength, and neuronal survival, as well as neuroprotection in ischemic preconditioning. Mechanistic studies of NO stimulation of K ATP may also facilitate treatments for ischemic or traumatic injury and neurodegenerative diseases.
